Scleroderma Treatment With Autologous Transplant (STAT) Study
Condition:   Systemic SclerodermaInterventions:   Procedure: peripheral blood stem cell transplantation;   Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Other: questionnaire administration;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Biological: filgrastim;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: mycophenolate mofetil;   Drug: plerixaforSponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium;   National Cancer Institu...
Source: ClinicalTrials.gov - August 8, 2011 Category: Research Source Type: clinical trials